Evaluation of Endoscopic Thyroidectomy Via Axillo-breast Approach in Thyroid Nodules (Thyroidectomy)

March 30, 2020 updated by: Ahmed Gamal Hemdan, Assiut University
Evaluation of Endoscopic Thyroidectomy via Axillo-breast Approach in Thyroid Nodules regarding safety and cosmetic outcomes

Study Overview

Study Type

Observational

Enrollment (Anticipated)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Ahmed Mohamed Gamal

Study Locations

      • Assiut, Egypt, 71111
        • Recruiting
        • Ahmed Gamal
        • Contact:
          • Ahmed Mohamed Gamal

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 55 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

30 patients age group 18_55 years with unilateral or bilateral thyroid nodules benign according to preoperative FNAC and normal thyroid function

Description

Inclusion Criteria:

  • benign thyroid nodules unilateral or bilateral Normal thyroid function

Exclusion Criteria:

  • malignant Thyroid Nodules Recurrent goitre Toxic goitre

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Intervention group
Endoscopic thyroidectomy in Thyroid Nodules

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Safety of Endoscopic Thyroidectomy
Time Frame: 2020_2023
2020_2023

Secondary Outcome Measures

Outcome Measure
Time Frame
Cosmetic outcome of Endoscopic Thyroidectomy
Time Frame: 2020_2023
2020_2023

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

April 1, 2020

Primary Completion (Anticipated)

April 1, 2022

Study Completion (Anticipated)

April 1, 2023

Study Registration Dates

First Submitted

March 30, 2020

First Submitted That Met QC Criteria

March 30, 2020

First Posted (Actual)

April 1, 2020

Study Record Updates

Last Update Posted (Actual)

April 1, 2020

Last Update Submitted That Met QC Criteria

March 30, 2020

Last Verified

March 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Safety and Cosmetic Issues in Endoscopic Thyroidectomy

Clinical Trials on Endoscopic thyroidectomy

Subscribe